Prediction of pulmonary hypertension using chest-computed tomography in patients with pulmonary sarcoidosis Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015
Predicting pulmonary hypertension with standard computed tomography angiography Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013
Quantifying pulmonary perfusion in primary pulmonary hypertension using electron-beam computed tomography Source: Eur Respir J 2004; 23: 202-207 Year: 2004
Measurement of small pulmonary vessels by using computed tomography (CT) in COPD patients with severe pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014
Correlation of ECG-gated 320-row multidetector computed tomography measurement of pulmonary arterial distensibility with hemodynamic factors in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013
Quantitative evaluation of ventilation-perfusion heterogeneity in precapillary pulmonary hypertension with SPECT scintigraphy Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots Year: 2015
Lung perfusion: MRI vs SPECT for screening in suspected chronic thromboembolic pulmonary hypertension Source: International Congress 2016 – Acute pulmonary embolism Year: 2016
Usefulness of optical coherence tomography for diagnosis and treatment in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013
18F-fluorodeoxyglucose (18FDG) PET pulmonary imaging in COPD Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment Year: 2015
Role of quantitative computed tomography in patients with severe precapillary pulmonary hypertension Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle Year: 2018
(18)F-FDG positron emission tomography/computed tomography and pulmonary function in sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013
18-FDG uptake on PET-CT and metabolism in pulmonary arterial hypertension. Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021
18F-Fluorodeoxyglucose (18FDG) PET pulmonary imaging: Role in detecting vascular inflammation Source: International Congress 2015 – CT, PET, MRI modalities: fusion of anatomical and functional variables for lung assessment Year: 2015
Fluorine-18-fluorodeoxyglucose positron emission tomography (18F-FDGPET) may be useful in the management of sarcoidosis Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations Year: 2014
Pulmonary perfusion quantified by electron-beam computed tomography: effects of hypoxia and inhaled NO Source: Eur Respir J 2003; 21: 855-861 Year: 2003
Value of chest radiography in predicting pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: chronic thromboembolic pulmonary hypertension, imaging and biomarkers Year: 2013
Importance of computed tomography in defining segmental disease in chronic thromboembolic pulmonary hypertension Source: ERJ Open Res, 6 (4) 00461-2020; 10.1183/23120541.00461-2020 Year: 2020
18F-fluorodeoxyglucose (18FDG) PET pulmonary imaging:comparative methodology in COPD patients Source: International Congress 2014 – COPD and PAH related imaging Year: 2014
Pulmonary veno-occlusive disease Source: Eur Respir J 2009; 33: 189-200 Year: 2009
Pulmonary atherosclerosis observed by intravascular ultrasound Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013